Skip to main content
Premium Trial:

Request an Annual Quote

Expression Analysis Becomes CSP for Agilent's SureSelect

NEW YORK (GenomeWeb News) – Agilent Technologies today announced that Expression Analysis is now a certified service provider for its SureSelect Target Enrichment System for next-generation sequencing.

Expression Analysis, based in Durham, NC, is the second company this year to achieve CSP status with Agilent for the SureSelect product, which was introduced in 2009, following the naming of BGI as a CSP for the SureSelect XT Target Enrichment System in the spring.

There are currently more than 20 products in the SureSelect portfolio.

Expression Analysis completed comprehensive on-site training and then passed a "rigorous set of requirements to demonstrate expertise and skill," in order to gain CSP status, the companies said.

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.